Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof

Details for Australian Patent Application No. 2007285257 (hide)

Owner Cosmo Oil Co., Ltd.

Inventors Tachiya, Naohisa

Agent Spruson & Ferguson

Pub. Number AU-B-2007285257

PCT Pub. Number WO2008/020532

Priority 2006-221538 15.08.06 JP

Filing date 24 July 2007

Wipo publication date 21 February 2008

Acceptance publication date 1 December 2011

International Classifications

C07C 229/22 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

A61K 31/19 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

B01D 9/02 (2006.01) Crystallisation

C07C 227/42 (2006.01) Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

20 November 2008 PCT application entered the National Phase

  PCT publication WO2008/020532 Priority application(s): WO2008/020532

1 December 2011 Application Accepted

  Published as AU-B-2007285257

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007285277-Artificial hair and wig using the same

2007285217-Diagnosis and treatment of cancer using anti-desmoglein-3 antibody